Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer

Turk Patoloji Dergisi - Turkey
doi 10.5146/tjpath.2010.01028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Federation of Turkish Pathology Societies

Related search

High Concordance Between Immunohistochemistry and Fluorescence in Situ Hybridization Testing for HER2 Status in Breast Cancer Requires a Normalized IHC Scoring System

Modern Pathology
Forensic MedicinePathology
2008English

Necessity of in Situ Hybridization Test of Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer Patients With Equivocal HER2 Immunohistochemistry Results

Journal of Breast Disease
2018English

Review of HER2 Immunohistochemistry and in Situ Hybridisation Concordance in Breast Cancer

Pathology
Forensic MedicinePathology
2020English

Assessment of HER2 Status in Breast Cancer: Overall Positivity Rate and Accuracy by Fluorescence in Situ Hybridization and Immunohistochemistry in a Single Institution Over 12 Years: A Quality Control Study

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

Strong Correlation Between Results of Fluorescent in Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma

Modern Pathology
Forensic MedicinePathology
2000English

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-Time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence in Situ Hybridization

Clinical Cancer Research
Cancer ResearchOncology
2005English

Quantitative Analysis of HER2 mRNA Expression by RNA in Situ Hybridization in Canine Mammary Gland Tumors: Comparison With Immunohistochemistry Analysis

PLoS ONE
Multidisciplinary
2020English

Positive Response to Neoadjuvant Cyclophosphamide and Doxorubicin in Topoisomerase II Nonamplified/Her2/Neu Negative/Polysomy 17 Absent Breast Cancer Patients

Cancer Management and Research
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy